Elrexfio savings card: as little as $0 a treatment with commercial insurance

How to pay the least

Ask for the cash price

Elrexfio

Elrexfio is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Elrexfio’s cash price, and one or two other pharmacies too.
Elrexfio’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameElrexfio

Authorized genericelranatamab-bcmm

Regular genericelranatamab-bcmm

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Elrexfio?

The original

–

Brand nameThe maker’s card

Pfizer Oncology Together Co-pay Savings Program for Injectables (ELREXFIO)

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a treatment

The card takes up to $25,000 a year off your co-pay.

Or call 1-877-744-5675.

In the maker’s words

“Eligible patients with commercial insurance may pay as little as $0 for each ELREXFIO treatment…”

From the maker’s offer on elrexfio.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Elrexfio itself, from the same company, sold without the brand name, and usually for less. For now Elrexfio is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Elrexfio is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Multiple myeloma that came back or stopped responding

What the FDA label says

ELREXFIO is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T‑cell engager indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).

Source: the FDA label for Elrexfio (Pfizer Laboratories Div Pfizer Inc), September 14, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/elrexfio/